CCL5 and neoplasm: An experimental model of low-grade optic gliomas with mutation of neurofibromin 1 (NF1) showed increased expression of chemokine C-C ligand 5 (CCL5), along with other chemokines responsible for tumor growth, and increased attraction of T cells and microglia into tumor tissue [4].